These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4853886)

  • 41. Haemolysis induced by ascorbic acid in paroxysmal nocturnal haemoglobinuria.
    Iwamoto N; Kawaguchi T; Horikawa K; Nagakura S; Hidaka M; Kagimoto T; Takatsuki K; Nakakuma H
    Lancet; 1994 Feb; 343(8893):357. PubMed ID: 7905165
    [No Abstract]   [Full Text] [Related]  

  • 42. The uptake of 3H-choline by paroxysmal nocturnal haemoglobinuria red blood cells, reticulocytes and energy depleted erythrocytes.
    Corrocher R; Falezza G; Pennacchioni A; Capra F; Olivieri O; De Sandre G
    Haematologica; 1980 Apr; 65(2):151-7. PubMed ID: 6769755
    [No Abstract]   [Full Text] [Related]  

  • 43. Paroxysmal nocturnal hemoglobinuria. Alternate-complement-pathway-mediated lysis induced by magnesium.
    May JE; Rosse W; Frank MM
    N Engl J Med; 1973 Oct; 289(14):705-9. PubMed ID: 4727529
    [No Abstract]   [Full Text] [Related]  

  • 44. Variations in the red cells in paroxysmal nocturnal haemoglobinuria.
    Rosse WF
    Br J Haematol; 1973 Mar; 24(3):327-42. PubMed ID: 4713634
    [No Abstract]   [Full Text] [Related]  

  • 45. Abnormality of phospholipids in red cells of patients with paroxysmal nocturnal haemoglobinuria.
    HARRIS IM; PRANKERD TA; WESTERMAN MP
    Br Med J; 1957 Nov; 2(5056):1276-7. PubMed ID: 13479696
    [No Abstract]   [Full Text] [Related]  

  • 46. [Changes in the cholinergic activity of the blood in patients with paroxysmal nocturnal hemoglobinuria].
    Savina LS; Sokolinskaia RA; Lobanova NA
    Probl Gematol Pereliv Krovi; 1975 Mar; 20(3):40-4. PubMed ID: 1219720
    [No Abstract]   [Full Text] [Related]  

  • 47. Proceedings: The membrane lesion in PNH and PNH-like red cells.
    Righetti PG; Perrella M; Zanella A; Sirchia G
    Ital J Biochem; 1974; 23(4):276-7. PubMed ID: 4443212
    [No Abstract]   [Full Text] [Related]  

  • 48. The haemolytic action of dapsone: changes in the red-cell membrane.
    Rasbridge MR; Scott GL
    Br J Haematol; 1973 Feb; 24(2):183-93. PubMed ID: 4713625
    [No Abstract]   [Full Text] [Related]  

  • 49. The fatty-acid composition of red cells in paroxysmal nocturnal haemoglobinuria.
    LEIBETSEDER F; AHRENS EH
    Br J Haematol; 1959 Oct; 5():356-64. PubMed ID: 14415418
    [No Abstract]   [Full Text] [Related]  

  • 50. Paroxysmal nocturnal haemoglobinuria; electronmicroscopic study of red blood-cells.
    CECCHI E; CONESTABILE E
    Lancet; 1957 Sep; 273(6993):466-8. PubMed ID: 13464093
    [No Abstract]   [Full Text] [Related]  

  • 51. Study of the acetylcholinesterase activity of AET-treated (2-aminoethylisothiouronium bromide) normal red cells (PNH-like cells).
    Ferrone S; Zanella A; Sirchia G
    Acta Vitaminol Enzymol; 1970; 24(6):222-5. PubMed ID: 5537936
    [No Abstract]   [Full Text] [Related]  

  • 52. pH dependent hemolytic systems. I. Their relationship to paroxysmal nocturnal hemoglobinuria.
    YACHNIN S; LAFORET MT; GARDNER FH
    Blood; 1961 Jan; 17():83-96. PubMed ID: 13787034
    [No Abstract]   [Full Text] [Related]  

  • 53. [Acetylcholinesterase deficiency in red blood cells in nocturnal paroxysmal hemoglobinuria].
    DE SANDRE G; GHIOTTO G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1962; 78():646-9. PubMed ID: 13884522
    [No Abstract]   [Full Text] [Related]  

  • 54. Some red cell enzyme activities in paroxysmal nocturnal haemoglobinuria.
    Sirchia G; Ferrone S; Nocca G
    Enzymol Biol Clin (Basel); 1966; 7(3):145-8. PubMed ID: 5965865
    [No Abstract]   [Full Text] [Related]  

  • 55. Paroxysmal nocturnal hemoglobinuria. Hemolysis initiated by the C3 activator system.
    Götze O; Müller-Eberhard HJ
    N Engl J Med; 1972 Jan; 286(4):180-4. PubMed ID: 5007123
    [No Abstract]   [Full Text] [Related]  

  • 56. The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria.
    HINZ CF; JORDAN WS; PILLEMER L
    J Clin Invest; 1956 May; 35(5):453-7. PubMed ID: 13319478
    [No Abstract]   [Full Text] [Related]  

  • 57. Erythrocyte membrane interactions with menadione and the mechanism of menadione-induced hemolysis.
    Mezick JA; Settlemire CT; Brierley GP; Barefield KP; Jensen WN; Cornwell DG
    Biochim Biophys Acta; 1970 Dec; 219(2):361-71. PubMed ID: 5497195
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cholinergic mechanisms in the formation of the population of defective erythrocytes in paroxysmal nocturnal hemoglobinuria].
    Savina LS; Ivanova IV
    Sov Med; 1981; (1):39-42. PubMed ID: 7244780
    [No Abstract]   [Full Text] [Related]  

  • 59. Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.
    Medof ME; Gottlieb A; Kinoshita T; Hall S; Silber R; Nussenzweig V; Rosse WF
    J Clin Invest; 1987 Jul; 80(1):165-74. PubMed ID: 2439544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paroxysmal nocturnal hemoglobinuria. II. Permeability and phosphate turnover in the red blood cells.
    HELLEM AJ; SKAUG OE
    Scand J Clin Lab Invest; 1955; 7(2):121-5. PubMed ID: 13255805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.